Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT00702221
Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension
Phase: Phase 2
Role: Collaborator
Start: Jun 30, 2008
Completion: Sep 30, 2010